Clinical Trial

The Efficacy of Aldehyde Dehydrogenase Enzyme in Essential Tremor Patients: A Single-Center Study

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated November 20, 2025 (before its estimated February 28, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a sponsor-initiated, single-arm, single-center clinical trial designed to evaluate the efficacy and safety of an ALDH-containing food supplement (PICOZYME ET) in patients with Essential Tremor (ET). Participants will consume the investigational product daily for three months, and clinical outcomes will be assessed using the Clinical Rating Scale for Tremor (CRST) and the Activities of Daily Living (ADL) scale. Additional exploratory analyses will evaluate changes in metabolic biomarkers and brain function via imaging and blood tests.
Trial Details
NCT Number NCT07238725
Lead Sponsor Pico Entech Co., Ltd.
Collaborators: Korea University Anam Hospital
Conditions Essential Tremor
Enrollment 40 participants
Start Date 2025-03-10
Primary Completion 2026-02-28 (estimated)
Study Completion 2026-02-28 (estimated)
Updated on ClinicalTrials.gov 2025-11-20